Interact to see
Advertisement
Advertisement
NRGEX vs PCSMX
NRGEX vs PCSMX Comparison
Open Charts NRGEX vs PCSMX
Neuberger Berman Genesis E
Price$64.16
Change-$0.59 (-0.91%)
VolumeN/A
Net Assets9.11B
Principal SmallCap Growth I R6
Price$15.40
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets2.07B
NRGEX vs PCSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NRGEX has more cash in the bank: 9.11B vs. PCSMX (2.07B). PCSMX pays higher dividends than NRGEX: PCSMX (0.59) vs NRGEX (0.54). NRGEX was incepted earlier than PCSMX: NRGEX (4 years) vs PCSMX (11 years). PCSMX (0.90) is less costly to investors than NRGEX (0.69). PCSMX is a more actively managed with annual turnover of: 61.20 vs. NRGEX (13.00). NRGEX (0) and PCSMX (0) have matching initial minimum investment requirements. PCSMX annual gain was more profitable for investors over the last year : 1.44 vs. NRGEX (-2.66).
| NRGEX | PCSMX | NRGEX / PCSMX | |
| Total Expense Ratio | 0.03 | 0.87 | 3% |
| Annual Report Gross Expense Ratio | 0.69 | 0.90 | 77% |
| Fund Existence | 4 years | 11 years | - |
| Gain YTD | -2.076 | 3.356 | -62% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.11B | 2.07B | 441% |
| Annual Yield % from dividends | 0.54 | 0.59 | 91% |
| Returns for 1 year | -2.66 | 1.44 | -184% |
| Returns for 3 years | -2.78 | 12.16 | -23% |
| Returns for 5 years | N/A | 0.78 | - |
| Returns for 10 years | N/A | 19.79 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAWZ | 57.83 | 0.07 | +0.12% |
| ProShares Pet Care ETF | |||
| FCBD | 25.59 | 0.01 | +0.05% |
| Frontier Asset Core Bond ETF | |||
| AWF | 11.12 | -0.05 | -0.45% |
| ALLIANCEBERSTEIN GLOBAL HIGH Income FUND | |||
| ISCB | 60.85 | -0.34 | -0.56% |
| iShares Morningstar Small-Cap ETF | |||
| BIS | 14.27 | -0.28 | -1.93% |
| ProShares UltraShort Nasdaq Biotech | |||